HFUS
Hartford Great Health Corp. [HFUS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
HFUS Stock Summary
In the News
HFUS Financial details
Company Rating
Strong Sell
Market Cap
60.07M
Income
-108.28K
Revenue
-124.51K
Book val./share
-0.05
Cash/share
0
Dividend
-
Dividend %
-
Employees
5
Optionable
No
Shortable
Yes
Earnings
30 Apr 2023
P/E
-1739.91
Forward P/E
-
PEG
185.52
P/S
-
P/B
-19.94
P/C
-
P/FCF
-370.22
Quick Ratio
-
Current Ratio
-
Debt / Equity
-0.97
LT Debt / Equity
-
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-122.6%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-33.33%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-327%
ROE
1%
ROC
0.02%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.43-3.0
52W High
-
52W Low
-
RSI
56
Rel Volume
43.67
Avg Volume
91
Volume
3.97K
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
20.02%
-
-
-
-
Beta
2.597
-
-
Volatility
0.17%, 0.17%
Prev Close
0%
Price
0.6001
Change
-39.99%
HFUS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-07-31
| Metric | History | 2019-07-31 | 2020-07-31 | 2021-07-31 | 2022-07-31 | 2023-07-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0.01 | 0.01 | 0 | |
| Net income per share | -0.01 | -0.04 | -0.03 | -0.02 | 0 | |
| Operating cash flow per share | -0.02 | 0 | -0.02 | -0.01 | 0 | |
| Free cash flow per share | -0.02 | -0.01 | -0.03 | -0.01 | 0 | |
| Cash per share | 0 | 0 | 0 | 0 | 0 | |
| Book value per share | 0.02 | -0.01 | -0.04 | -0.05 | -0.04 | |
| Tangible book value per share | 0 | -0.02 | -0.05 | -0.06 | -0.04 | |
| Share holders equity per share | 0.02 | -0.01 | -0.04 | -0.05 | -0.04 | |
| Interest debt per share | 0.01 | 0.05 | 0.1 | 0.04 | 0.04 | |
| Market cap | 92.19M | 118.93M | 20.96M | 15.62M | 88.1M | |
| Enterprise value | 92.51M | 123.89M | 30.64M | 20.08M | 92.46M | |
| P/E ratio | -160.94 | -32.54 | -7.37 | -8.81 | 221.96 | |
| Price to sales ratio | 1.64K | 1.21K | 37.86 | 27.82 | 0 | |
| POCF ratio | -73.18 | -266.19 | -8.8 | -18.14 | -714.11 | |
| PFCF ratio | -72.96 | -165.73 | -8.22 | -15.53 | -714.11 | |
| P/B Ratio | 69.3 | -86.83 | -5.54 | -3.04 | -19.62 | |
| PTB ratio | 69.3 | -86.83 | -5.54 | -3.04 | -19.62 | |
| EV to sales | 1.65K | 1.26K | 55.36 | 35.78 | 0 | |
| Enterprise value over EBITDA | -138.32 | -718.58 | -11.1 | -11.47 | -792.46 | |
| EV to operating cash flow | -73.43 | -277.28 | -12.87 | -23.33 | -749.47 | |
| EV to free cash flow | -73.21 | -172.64 | -12.02 | -19.97 | -749.47 | |
| Earnings yield | -0.01 | -0.03 | -0.14 | -0.11 | 0 | |
| Free cash flow yield | -0.01 | -0.01 | -0.12 | -0.06 | 0 | |
| Debt to equity | 0.46 | -3.64 | -2.57 | -0.87 | -0.97 | |
| Debt to assets | 0.16 | 0.79 | 1.69 | 0.99 | 562.28 | |
| Net debt to EBITDA | -0.47 | -28.75 | -3.51 | -2.55 | -37.38 | |
| Current ratio | 0.98 | 0.22 | 0.13 | 0.1 | 0 | |
| Interest coverage | 0 | 0 | -95.38 | 28.14 | -6.95 | |
| Income quality | 1.91 | 0.12 | 0.84 | 0.49 | -0.31 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 12.31 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.28 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0.61 | 0.07 | 0.17 | 0 | |
| Capex to revenue | -0.07 | -2.75 | -0.3 | -0.26 | 0 | |
| Capex to depreciation | -0.27 | -3.87 | -1.98 | -1.19 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.07 | 0.11 | 0.16 | 0.14 | 0.06 | |
| ROIC | -0.26 | -0.22 | -0.28 | 2.83 | 1.01 | |
| Return on tangible assets | -0.22 | -0.58 | -0.49 | -0.39 | 51.1 | |
| Graham Net | -0.02 | -0.08 | -0.1 | -0.11 | -0.04 | |
| Working capital | -25.82K | -3.36M | -6.93M | -7.65M | -4.49M | |
| Tangible asset value | 209.26K | -2.29M | -4.99M | -6.43M | -4.49M | |
| Net current asset value | -947.01K | -7.61M | -9.74M | -10.16M | -4.49M | |
| Invested capital | 0.46 | -3.64 | -2.57 | -0.87 | -0.97 | |
| Average receivables | 410.61K | 874.06K | 769.5K | 313.74K | 8.32K | |
| Average payables | 22.42K | 77.22K | 55.22K | 0 | 0 | |
| Average inventory | 12.3K | -451.15K | -301.54K | 161.91K | -622 | |
| Days sales outstanding | 5.34K | 3.44K | 403.67 | 10.01 | 0 | |
| Days payables outstanding | 1.4K | 467.37 | 0 | 0 | 0 | |
| Days of inventory on hand | 784.47 | -3.92K | 383.23 | 0 | -65.09 | |
| Receivables turnover | 0.07 | 0.11 | 0.9 | 36.48 | 0 | |
| Payables turnover | 0.26 | 0.78 | 0 | 0 | 0 | |
| Inventory turnover | 0.47 | -0.09 | 0.95 | 0 | -5.61 | |
| ROE | -0.43 | 2.67 | 0.75 | 0.34 | -0.09 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2024-01-31 for Q2
| Metric | History | 2023-01-31 | 2023-04-30 | 2023-07-31 | 2023-10-31 | 2024-01-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | 0 | 0 | 0 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 0 | 0 | 0 | 0 | |
| Book value per share | -0.05 | -0.05 | -0.04 | -0.04 | -0.05 | |
| Tangible book value per share | -0.05 | -0.05 | -0.04 | -0.04 | -0.05 | |
| Share holders equity per share | -0.05 | -0.05 | -0.04 | -0.04 | -0.05 | |
| Interest debt per share | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | |
| Market cap | 15.62M | 110.12M | 88.1M | 88.1M | 50.05M | |
| Enterprise value | 20.22M | 114.65M | 92.46M | 92.39M | 54.49M | |
| P/E ratio | 103.7 | -888.94 | -691.38 | -865.17 | -625.77 | |
| Price to sales ratio | 83.53 | 0 | -471.22 | 0 | 801.6 | |
| POCF ratio | -428.92 | -5.52K | -2.19K | -4.38K | -3.53K | |
| PFCF ratio | -428.92 | -5.52K | -2.19K | -4.38K | -3.53K | |
| P/B Ratio | -3.35 | -23.97 | -19.62 | -19.94 | -10.97 | |
| PTB ratio | -3.35 | -23.97 | -19.62 | -19.94 | -10.97 | |
| EV to sales | 108.13 | 0 | -494.55 | 0 | 872.57 | |
| Enterprise value over EBITDA | -946.31 | -5.35K | -3.53K | -4.59K | -3.65K | |
| EV to operating cash flow | -555.21 | -5.75K | -2.3K | -4.59K | -3.84K | |
| EV to free cash flow | -555.21 | -5.75K | -2.3K | -4.59K | -3.84K | |
| Earnings yield | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | -0.99 | -0.99 | -0.97 | -0.97 | -0.97 | |
| Debt to assets | 56.87 | 53.8 | 562.28 | 277.86 | 429.97 | |
| Net debt to EBITDA | -215.25 | -211.41 | -166.32 | -213.43 | -296.64 | |
| Current ratio | 0.02 | 0.02 | 0 | 0 | 0 | |
| Interest coverage | -5.22 | -4.48 | 0.85 | -3.84 | -2.96 | |
| Income quality | 1.43 | 0.76 | 1.26 | 0.79 | 0.71 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
| ROIC | -0.56 | 0.5 | 0.22 | 0.18 | 0.12 | |
| Return on tangible assets | 0.46 | -0.37 | -4.1 | -1.64 | -1.94 | |
| Graham Net | -0.05 | -0.05 | -0.04 | -0.04 | -0.05 | |
| Working capital | -4.67M | -4.6M | -4.49M | -4.42M | -4.56M | |
| Tangible asset value | -4.67M | -4.59M | -4.49M | -4.42M | -4.56M | |
| Net current asset value | -4.67M | -4.6M | -4.49M | -4.42M | -4.56M | |
| Invested capital | -0.99 | -0.99 | -0.97 | -0.97 | -0.97 | |
| Average receivables | 60.62K | 61.76K | 31.15K | 1.24K | 1.1K | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | -60.47K | -61.62K | -31.15K | -1.24K | -618.5 | |
| Days sales outstanding | 30.07 | 0 | -0.6 | 0 | 1.39 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | -19.33 | 0 | -0.39 | -1.41K | 0 | |
| Receivables turnover | 2.99 | 0 | -150.28 | 0 | 64.77 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | -4.66 | 0 | -232.71 | -0.06 | 0 | |
| ROE | -0.01 | 0.01 | 0.01 | 0.01 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
HFUS Frequently Asked Questions
What is Hartford Great Health Corp. stock symbol ?
Hartford Great Health Corp. is a US stock , located in Rosemead of Ca and trading under the symbol HFUS
What is Hartford Great Health Corp. stock quote today ?
Hartford Great Health Corp. stock price is $0.6001 today.
Is Hartford Great Health Corp. stock public?
Yes, Hartford Great Health Corp. is a publicly traded company.
Company Profile
- Volume Average 91
- Market Capitalization 60.07M
- Employee 5
- CEO Mr. Sheng-Yih Chang
- Headquarters Rosemead,CA,US
- IPO Date 2012-04-05
-
Website
http://www.hfgreathealth.com 
Hartford Great Health Corp. provides hospitality services. It operates through Hospitality and Education segments. The company provides hotel and travel agency services. It also offers early childhood education services, such as parent-child and bilingual childcare classes. The company was formerly known as PhotoAmigo, Inc. and changed its name to Hartford Great Health Corp. in August 2018. Hartford Great Health Corp. was incorporated in 2008 and is based in Rosemead, California.
